Amy E. Tapper - 20 Jul 2022 Form 4 Insider Report for Imago BioSciences, Inc.

Role
Senior Vice President, Non-Clinical and CMC
Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Amy Tapper
Issuer symbol
N/A
Transactions as of
20 Jul 2022
Net transactions value
-$11,535
Form type
4
Filing time
21 Jul 2022, 17:49:42 UTC
Previous filing
15 Feb 2022
Next filing
16 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Options Exercise $1,890 +750 +0.63% $2.52* 119,797 20 Jul 2022 Direct F1
transaction IMGO Common Stock Sale $13,425 -750 -0.63% $17.90 119,047 20 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -750 -1.1% $0.000000 64,982 20 Jul 2022 Common Stock 750 $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Remarks:

Senior Vice President, Non-Clinical and CMC